Disease-relevant autoantibodies in first episode schizophrenia
about
Neuroinflammation and psychiatric illnessDetection and Characterization of Autoantibodies to Neuronal Cell-Surface Antigens in the Central Nervous SystemAutoantibodies to central nervous system neuronal surface antigens: psychiatric symptoms and psychopharmacological implicationsInflammation and immunity in schizophrenia: implications for pathophysiology and treatmentAnti-N-methyl-d-aspartate receptor encephalitis: review of clinical presentation, diagnosis and treatmentClinical and experimental studies of potentially pathogenic brain-directed autoantibodies: current knowledge and future directionsThe neuroimmunology of schizophreniaGlutamatergic autoencephalitides: an emerging fieldCell-surface central nervous system autoantibodies: clinical relevance and emerging paradigmsAutoimmune encephalitis in psychiatric institutions: current perspectivesPrevalence of anti-N-methyl-D-aspartate (NMDA) receptor [corrected] antibodies in patients with schizophrenia and related psychoses: a systematic review and meta-analysisAutoimmune encephalopathies.Inflammation and the two-hit hypothesis of schizophrenia.Anti-NMDA-receptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features.IL1R2, CCR2, and CXCR4 May Form Heteroreceptor Complexes with NMDAR and D2R: Relevance for Schizophrenia.Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study.Emergence of new-onset psychotic disorder following recovery from LGI1 antibody-associated limbic encephalitis.The Clinical Challenge of Autoimmune Psychosis: Learning from Anti-NMDA Receptor Autoantibodies.Six autoantibodies associated with autoimmune encephalitis are not detectable in the cerebrospinal fluid of suicide attempters.Anti-N-Methyl-D-aspartate Receptor Encephalitis: A Severe, Potentially Reversible Autoimmune Encephalitis.Neuronal Surface Autoantibodies in Neuropsychiatric Disorders: Are There Implications for Depression?Recent advances in understanding schizophreniaSerum IgG antibodies against the NR1 subunit of the NMDA receptor not detected in schizophrenia.Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders.Investigation of neuronal autoantibodies in two different focal epilepsy syndromes.Anti-NMDA Receptor Encephalitis in PsychiatryAnti-NMDA receptor antibodies in patients with a first episode of schizophreniaDifferent rates of first admissions for psychosis in migrant groups in Paris.Prevalence of serum N-methyl-D-aspartate receptor autoantibodies in refractory psychosis.The risk of schizophrenia and child psychiatric disorders in offspring of mothers with lung cancer and other types of cancer: a Danish nationwide register studyCurrent approaches to the treatment of paraneoplastic encephalitis.The 4th Schizophrenia International Research Society Conference, 5-9 April 2014, Florence, Italy: a summary of topics and trends.Anti-N-methyl-d-aspartate receptor encephalitis in a patient with a 7-year history of being diagnosed as schizophrenia: complexities in diagnosis and treatmentFact or fiction? Examining a role for N-methyl-D-aspartate receptor autoantibodies in psychiatric illness.Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognitionPrevalence of elevated serum anti-N-methyl-D-aspartate receptor antibody titers in patients presenting exclusively with psychiatric symptoms: a comparative follow-up study.Anti-AMPA-Receptor Encephalitis Presenting as a Rapid-Cycling Bipolar Disorder in a Young Woman with Turner Syndrome.A case of GABAR antibodies in schizophreniaAutoantibodies against the N-Methyl-d-Aspartate Receptor Subunit NR1: Untangling Apparent Inconsistencies for Clinical Practice.Prenatal maternal infection, neurodevelopment and adult schizophrenia: a systematic review of population-based studies.
P2860
Q21245244-DEA785CA-7BAA-4392-9B54-2D296DE57A36Q26746048-40216E58-17F6-4A1F-92E9-E71B468D56CEQ26775915-55B682E1-F230-4CAE-9614-95CB956EF2C8Q26781620-7614A142-3A2E-47DA-9778-3F6F6D645469Q26801897-F1B41C83-E9D4-4F0C-A6FE-8EF46B7D57BFQ26824216-89A1BFAE-84C0-457B-8677-37ADFE57C4E2Q26859392-FDBD8846-E0FC-4675-995C-27F7899DBFEBQ26992294-942A991A-5029-4588-A163-7F2E3ED5C801Q27006941-61A9046B-5BDE-495A-A77F-123B58EE3097Q28079666-D91C940A-278F-48E4-B21E-9C3BEB3AC986Q28303840-0A463D6E-B59F-442C-BB81-C66CE73A4181Q30389491-F8542528-E5E9-4206-BA44-D382A4C2CEEDQ30422062-7136FC40-4DB3-4A0F-B411-DCF29547D73AQ30463819-6EF14996-D825-44E1-93F9-5B755C4175A8Q33364911-8F1A687D-F436-4AFB-8838-1BD2F37F7842Q33551430-B099CBDA-8A76-4562-82AC-415A4DF50DEEQ33552867-9C312589-49F0-4095-A643-F2F4960D8870Q33577793-0C6040B4-38A2-4E5F-9ACB-9DF47DED2B38Q33610959-433FFCCA-14D4-4844-A572-729009802378Q33862239-7B0B22AA-57C4-474E-A3D5-D422C434FA61Q33871737-13B7007D-48C5-43BD-B16B-BADEB516C62CQ33942094-A1323849-1212-47A1-BF54-42C9BF699D2CQ33956303-92C3615B-D0F1-4947-804E-B09A056836AAQ34306084-042341A4-6366-4E79-8200-0A5A7AE8FBE6Q34402802-2DCAEFA5-45B9-47F9-B87F-11CC571CB854Q34661274-CF382576-33A2-4E73-8717-CCC40D6EA687Q34669114-C800AF14-140B-4F7F-B5F3-8E6C25B21B73Q34811849-3778DF97-5D3C-46D3-83F2-0F6932169E8BQ35035280-8C8D2B37-0908-4020-B95A-961B7B411C5FQ35041116-CEAB5CCE-70CC-4A9C-9951-E96D05FC411DQ35090428-77B904A4-775A-48A2-BBBB-F38DC7F1199CQ35382798-77D99B53-C9B4-4942-BE2B-11219D3A4DCCQ35746924-71E3035A-0683-47B5-AD00-A2F6D0DD32D3Q35770227-C3EF7F5F-57FA-4B93-B469-18AA9A84D0A9Q35947819-7ED4CD39-C1C2-4BDF-878E-4908417F8401Q36071538-8076FD4C-5105-4DB4-ADBB-D78EC6F4D575Q36162787-1DC2AD4C-A699-4B37-B820-E239C42B8D44Q36244627-8535613B-DB4A-4109-BA9A-EDDD20C15F86Q36309804-CBEA42B1-97C2-419A-9F8F-9EDB66494565Q36341320-C72979B4-21A4-41E4-BE94-5127D4B4857B
P2860
Disease-relevant autoantibodies in first episode schizophrenia
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Disease-relevant autoantibodies in first episode schizophrenia
@ast
Disease-relevant autoantibodies in first episode schizophrenia
@en
Disease-relevant autoantibodies in first episode schizophrenia
@nl
type
label
Disease-relevant autoantibodies in first episode schizophrenia
@ast
Disease-relevant autoantibodies in first episode schizophrenia
@en
Disease-relevant autoantibodies in first episode schizophrenia
@nl
prefLabel
Disease-relevant autoantibodies in first episode schizophrenia
@ast
Disease-relevant autoantibodies in first episode schizophrenia
@en
Disease-relevant autoantibodies in first episode schizophrenia
@nl
P2860
P50
P3181
P1433
P1476
Disease-relevant autoantibodies in first episode schizophrenia
@en
P2093
Alasdair J Coles
Bethan Lang
P2860
P2888
P3181
P356
10.1007/S00415-010-5788-9
P407
P50
P577
2011-04-01T00:00:00Z
P5875
P6179
1012246025